Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Thromboembolism × edoxaban × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 6 Venous Thrombosis 5 Venous Thromboembolism 2 Pulmonary Embolism 2 Thrombosis 1 Thromboembolism 1

Interventions

Dalteparin 4 Saline Solution 3 Gemcitabine 3 Enoxaparin 3 Warfarin 2 Tinzaparin 2 Heparin, Low-Molecular-Weight 2 Fondaparinux 2 Aspirin 2 130-nm albumin-bound paclitaxel 2 palbociclib 1 enoxaparin sodium 1 edoxaban 1 apixaban 1 alvocidib 1 Tranexamic Acid 1 Sodium Chloride 1 Sodium Bicarbonate 1 Rivaroxaban 1 Pentetic Acid 1 PEGPH20 1 Nadroparin 1 Minocycline 1 Ketoconazole 1 Heparin 1 Fluoridation 1 Estramustine 1 Doxorubicin 1 Docetaxel 1 Clopidogrel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04072068 2023-05-30

EDOI

Gruppo Oncologico Italiano di Ricerca Clinica

Phase 4 Completed

Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡